可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]O’Brien KD.Pathogenesis of calcific aortic valve disease: a disease process comes of age(and a good deal more)[J].Arterioscler Thromb Vasc Biol,2006,26(8):1721-1728.
[2]Pibarot P,Dumesnil JG.New concepts in valvular hemodynamics: implications for diagnosis and treatment of aortic stenosis[J].Can J Cardiol,2007,23(Suppl B):40B-47B.
[3]潘文志,葛均波.经导管主动脉瓣置入术2013年进展回顾[J].中国介入心脏病学杂志,2014,(01):52-54.
[4]Iung B,Baron G,Butchart EG,et al.A prospective survey of patients with valvular heart disease in Europe:The Euro Heart Survey on Valvular Heart Disease[J].Eur Heart J,2003,24(13):1231-1243.
[5]Holmes DR Jr,Mack MJ,Kaul S,et al.2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement[J].J Am Coll Cardiol,2012,59(13):1200-1254.
[6]Tsai MT,Tang GH,Cohen GN.Year in review:transcatheter aortic valve replacement[J].Curr Opin Cardiol,2016,31(2):139-147.
[7]Schymik G, Lefevre T, Bartorelli AL, et al. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis:1-year outcomes from the SOURCE XT Registry[J].JACC Cardiovasc Interv,2015,8(5):657-669.